A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

  title={A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome},
  author={A. Venket Rao and Alison C. Bested and Tracey M Beaulne and Martin A Katzman and Christina R. Di Iorio and John M Berardi and Alan C Logan},
  journal={Gut Pathogens},
  pages={6 - 6}
Chronic fatigue syndrome (CFS) is complex illness of unknown etiology. Among the broad range of symptoms, many patients report disturbances in the emotional realm, the most frequent of which is anxiety. Research shows that patients with CFS and other so-called functional somatic disorders have alterations in the intestinal microbial flora. Emerging studies have suggested that pathogenic and non-pathogenic gut bacteria might influence mood-related symptoms and even behavior in animals and humans… 
Probiotics for fibromyalgia: study design for a pilot double-blind, randomized controlled trial.
This pilot study is the first, to the authors' knowledge, to evaluate the effects of probiotics in FMS, with the primary hypothesis that FMS patients will show a better performance on cognitive tasks, and an improvement in emotional and physical symptoms.
Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: a double blind, randomized, placebo-controlled trial
Probing the effects of probiotics as adjunctive therapy on anxiety severity and quality of life (QOL) in patients with GAD found it was superior to sertraline alone in decreasing anxiety symptoms after 8 weeks, although it did not affect QOL.
A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue
This study demonstrates that a 14 days supplementation of ImmunoSEB + ProbioSEB CSC3 resolves post-COVID-19 fatigue and can improve patients’ functional status and quality of life.
Probiotics and Subclinical Psychological Symptoms in Healthy Participants: A Systematic Review and Meta-Analysis.
Results show that probiotic consumption may have a positive effect on psychological symptoms of depression, anxiety, and perceived stress in healthy human volunteers.


Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.
The results indicate a beneficial effect on gastrointestinal symptoms of patients with Chronic constipation and the administration of probiotic foodstuffs may be recommended as an adjunctive therapy of chronic constipation.
Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value.
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome.
Yakult is effective in altering fermentation patterns in the small bowel, consistent with reducing SIBO, and the loss of ERBHAL was associated with reduced symptoms.
Impact of consuming a milk drink containing a probiotic on mood and cognition
The consumption of a probiotic-containing yoghurt improved the mood of those whose mood was initially poor, and this improvement in mood was not, however, associated with an increased frequency of defaecation.
Major depressive disorder: probiotics may be an adjuvant therapy.
The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat.
Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria.
The results show that normalization of the IgA and IgM responses to translocated LPS may predict clinical outcome in CFS, and support the view that a weakened tight junction barrier with subsequent gut-derived inflammation is a novel pathway inCFS and that it is a new target for drug development in C FS.
Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.
Preliminary evidence is provided that patients with CFS, FM, and TMD share key symptoms, and it also is apparent that other localized and systemic conditions may frequently co-occur with C FS,FM, andTMD.
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?
Multivariate statistical analyses suggest that gastrointestinal disorders, psychiatric disorders, and nongastrointestinal somatic disorders are distinct disorders and not manifestations of a common somatization disorder, but their strong comorbidity suggests a common feature important to their expression, which is most likely psychological.
An examination of the working case definition of chronic fatigue syndrome.